Riluzole.: New study below [1]. The... - Advanced Prostate...

Advanced Prostate Cancer

21,852 members27,367 posts

Riluzole.

pjoshea13 profile image
4 Replies

New study below [1].

The androgen receptor [AR] remains the favorite target. We deprive them of androgen & gum them up with antiandrogens. We can target AR overexpression or accelerate AR decay.

"Riluzole (marketed as Rilutek and Teglutik) is a drug used to treat amyotrophic lateral sclerosis." [2]

Riluzole "downregulates AR-FL, mutant ARs, and AR-V7 proteins expression by protein degradation".

"Riluzole also significantly inhibited AR transcription activity by decreasing its target genes expression (PSA, TMPRSS2, and KLK2)."

-Patrick

[1] ncbi.nlm.nih.gov/pubmed/302...

[2] en.wikipedia.org/wiki/Riluzole

Written by
pjoshea13 profile image
pjoshea13
To view profiles and participate in discussions please or .
Read more about...
4 Replies
henukit profile image
henukit

New candidate for repurposing?

GP24 profile image
GP24

Interesting article. But it does not specify how many pills a day are required to achive a good result in humans.

GeorgeGlass profile image
GeorgeGlass

I found this drug while looking for depression treatments and then saw how it affects prostate cancer so I came on this site to see if it was mentioned. It's always interesting to see how few replies there are to the more complex issues. Plus, this kind of drug probably isn't easy to get access too. I'm going to check with my behavioral health doc to see what she has to say about it.

pjoshea13 profile image
pjoshea13 in reply to GeorgeGlass

Thanks George! -Patrick

Not what you're looking for?

You may also like...

Quercetin & AR-V7.

New study below [1]. A common form of resistance to Xtandi & Zytiga is the emergence of androgen...

Androgen Receptor [AR] Degradation.

Ralph1966 has recently posted someting on DpC. To date, AR-axis targeted therapies have involved...

Melatonin - AR-V7 Splice Variant.

The study below [1] is a cell study from last year. I don't think it has been posted before. As...

Quercetin targets hnRNPA1 to overcome enzalutamide resistance in prostate cancer cells

"The suppression of AR-V7 by quercetin resensitizes enzalutamide-resistant prostate cancer cells...

Melatonin & AR-V7

New study below. AR-V7 [Androgen Receptor Splice Variant-7] is an Androgen Receptor [AR] mutation...